Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Henzen

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.
FEBS Letters|November 6, 1998
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast culturesC E van Roozendaal, A J Gillis, J G Klijn, et al.
British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Genetic alterations in ovarian borderline tumours and ovarian carcinomasM Schuyer, S C Henzen-Logmans, M E van der Burg, et al.
Cancer Research|February 17, 2000
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patientsJ A Foekens, H A Peters, M P Look, et al.
The New England Journal of Medicine|July 21, 2001
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutationH Meijers-Heijboer, B van Geel, W L van Putten, et al.
Cancer Research|April 29, 2000
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerE M Berns, J A Foekens, R Vossen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2021
Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trialL Bargetzi, C Brack, J Herrmann, et al.
Radiology|March 1, 1996
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNABR P Takes, P Knegt, J J Manni, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neckR P Takes, P Righi, C A Meeuwis, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.
FEBS Letters|November 6, 1998
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast culturesC E van Roozendaal, A J Gillis, J G Klijn, et al.
British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Genetic alterations in ovarian borderline tumours and ovarian carcinomasM Schuyer, S C Henzen-Logmans, M E van der Burg, et al.
Cancer Research|February 17, 2000
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patientsJ A Foekens, H A Peters, M P Look, et al.
The New England Journal of Medicine|July 21, 2001
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutationH Meijers-Heijboer, B van Geel, W L van Putten, et al.
Cancer Research|April 29, 2000
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerE M Berns, J A Foekens, R Vossen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2021
Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trialL Bargetzi, C Brack, J Herrmann, et al.
Radiology|March 1, 1996
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNABR P Takes, P Knegt, J J Manni, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neckR P Takes, P Righi, C A Meeuwis, et al.
Pageof 11